Illumina Inc.

(ILMN) Trade

By |

Profile

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates revenue from sequencing tools and dedicated consumables (73% of 2019 sales). Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications. Services account for 17% of sales and include basic maintenance services, clinical lab applications (such as noninvasive prenatal, oncology, and rare-disease screening), and whole genome sequencing.

Contact Information

Website: www.illumina.com
Email: ir@illumina.com
Main Phone: +1 858 202-4500
Address: 200 Illumina Way
State: CA
City / Town: San Diego
Country: US
Postal Code: 92122

Issuer Information

Exchange: NGS
CEO: Francis A. DeSouza
Employees: 7700
NAICS: Medical Laboratories(621511)

Equities News

View More

Profile

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates revenue from sequencing tools and dedicated consumables (73% of 2019 sales). Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications. Services account for 17% of sales and include basic maintenance services, clinical lab applications (such as noninvasive prenatal, oncology, and rare-disease screening), and whole genome sequencing.

Contact Information

Website: www.illumina.com
Email: ir@illumina.com
Main Phone: +1 858 202-4500
Address: 200 Illumina Way
State: CA
City / Town: San Diego
Country: US
Postal Code: 92122

Issuer Information

Exchange: NGS
CEO: Francis A. DeSouza
Employees: 7700
NAICS: Medical Laboratories(621511)

Equities News

View More
$ 295.50 $ -2.52 (-0.85%)
Last Price 295.50 Change $ -2.52 Change % -0.85 Tick N/A
Bid 291.20 Bid Size 100.00 Ask 298.50 Ask Size 200.00
Open 298.36 High 300.92 Low 290.83 Prev Close 298.02
Last Trade Volume 4.3 mi 52 Wk Hi 404.21 52 Wk Low 196.78
Market Cap 43.1 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 146,000,000.00 EPS (TTM) 4.68 PE Ratio 63.10 Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 45 258
Number of Buys 11 53
Number of Sells 34 205
Net Activity -5874 -86167
Last 10 Buys Shares
Gerald Moller 1,000
Last 10 Sell Shares
Francis A. DeSouza 1,000
Francis A. DeSouza 1,000
Francis A. DeSouza 1,000
Omead Ostadan 1,000
Karin Eastham 1,000
Karin Eastham 1,000
Karin Eastham 1,000
Robert S. Epstein 1,000
Mostafa Ronaghi 1,000
Jay T. Flatley 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 310 310 280 310
Low Target Price Estimate 195 180 180 195
Mean Target Price Estimate 264.07 258.07 255.4 264.07
Standard Deviation 27.82 31.99 28.87 27.82
Date of Most Recent Estimate 05/31/18 05/23/18 04/26/18 05/31/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 13 13 12 13
Moderate Buy 0 0 0 0
Hold 3 3 4 4
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 1
Mean Rec. 1.55 1.55 1.66 1.63